HLA expression in human hepatocellular carcinoma.

This study examines the expression of MHC class I and II antigens and their related invariant chains in 70 cases of human hepatocellular carcinoma (HCC), using monoclonal (Mabs) and polyclonal antibodies. In comparison with normal hepatocytes, the majority (94.3%) of HCCs show enhancement or acquisi...

Full description

Bibliographic Details
Main Authors: Paterson, A. C., Sciot, R., Kew, M. C., Callea, F., Dusheiko, G. M., Desmet, V. J.
Format: Online
Language:English
Published: Nature Publishing Group 1988
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246568/
id pubmed-2246568
recordtype oai_dc
spelling pubmed-22465682009-09-10 HLA expression in human hepatocellular carcinoma. Paterson, A. C. Sciot, R. Kew, M. C. Callea, F. Dusheiko, G. M. Desmet, V. J. Research Article This study examines the expression of MHC class I and II antigens and their related invariant chains in 70 cases of human hepatocellular carcinoma (HCC), using monoclonal (Mabs) and polyclonal antibodies. In comparison with normal hepatocytes, the majority (94.3%) of HCCs show enhancement or acquisition of HLA-A, B, C in either a cytoplasmic or membranous distribution, with staining being uniformly distributed throughout the specimen. HLA-A, B, C was accompanied by beta 2-microglobulin expression in all but two cases. Although 44.9% of specimens showed HLA-DR expression, positively staining tumour cells were often sparse and heterogeneously distributed. By contrast, the invariant (I) chain, present in 47.1% of cases, was frequently intensively stained and extensive in distribution. HLA-DR staining was usually cytoplasmic although two cases showed faint membranous enhancement. In addition to HLA-DR and I-chain, two cases also showed HLA-DQ staining. Display of MHC antigens was not related to tumour differentiation or size of the lesion (resected vs. advanced tumours). It is possible that the acquisition of class I antigens by the majority of HCCs may influence tumour behaviour. Nature Publishing Group 1988-04 /pmc/articles/PMC2246568/ /pubmed/2839219 Text en
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Paterson, A. C.
Sciot, R.
Kew, M. C.
Callea, F.
Dusheiko, G. M.
Desmet, V. J.
spellingShingle Paterson, A. C.
Sciot, R.
Kew, M. C.
Callea, F.
Dusheiko, G. M.
Desmet, V. J.
HLA expression in human hepatocellular carcinoma.
author_facet Paterson, A. C.
Sciot, R.
Kew, M. C.
Callea, F.
Dusheiko, G. M.
Desmet, V. J.
author_sort Paterson, A. C.
title HLA expression in human hepatocellular carcinoma.
title_short HLA expression in human hepatocellular carcinoma.
title_full HLA expression in human hepatocellular carcinoma.
title_fullStr HLA expression in human hepatocellular carcinoma.
title_full_unstemmed HLA expression in human hepatocellular carcinoma.
title_sort hla expression in human hepatocellular carcinoma.
description This study examines the expression of MHC class I and II antigens and their related invariant chains in 70 cases of human hepatocellular carcinoma (HCC), using monoclonal (Mabs) and polyclonal antibodies. In comparison with normal hepatocytes, the majority (94.3%) of HCCs show enhancement or acquisition of HLA-A, B, C in either a cytoplasmic or membranous distribution, with staining being uniformly distributed throughout the specimen. HLA-A, B, C was accompanied by beta 2-microglobulin expression in all but two cases. Although 44.9% of specimens showed HLA-DR expression, positively staining tumour cells were often sparse and heterogeneously distributed. By contrast, the invariant (I) chain, present in 47.1% of cases, was frequently intensively stained and extensive in distribution. HLA-DR staining was usually cytoplasmic although two cases showed faint membranous enhancement. In addition to HLA-DR and I-chain, two cases also showed HLA-DQ staining. Display of MHC antigens was not related to tumour differentiation or size of the lesion (resected vs. advanced tumours). It is possible that the acquisition of class I antigens by the majority of HCCs may influence tumour behaviour.
publisher Nature Publishing Group
publishDate 1988
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246568/
_version_ 1611439585207779328